Abstract
Conducting clinical trials is an extremely complex undertaking in one country let alone one involving multiple countries. In most cases, the trials are conducted in multiple countries due to strategic reasons in order to obtain regulatory approvals for the drug product or device under study. This has many aspects which include: intellectual property for the new product or device under study, the regulatory requirements in order to obtain market approval for the particular product or device, and last but not least cost considerations. This paper focuses on conducting clinical trials in order to obtain market approval outside the US.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
